Cart
sales@molnova.com
N-Benzyloleamide
CAS No. 883715-21-7
N-Benzyloleamide( —— )
Catalog No. M31462 CAS No. 883715-21-7
N-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 297 | In Stock |
|
| 100MG | 445 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Benzyloleamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
-
DescriptionN-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number883715-21-7
-
Formula Weight371.6
-
Molecular FormulaC25H41NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (124.49 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
New compound 12 (Rho...
New compound 12 (Rhoifolin analog)
-
[D-Trp2] Met-Enkepha...
[D-Trp2] Met-Enkephalin, amide
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
